Premas Biotech’s Covid vaccine candidate shows positive results in animal studies

By: |
August 27, 2020 9:26 PM

The company is in talks with the Indian regulatory authorities concerned to plan and initiate next steps towards conducting human trials, Premas Biotech said in a statement.

Multiple companies are developing Covid vaccine in India

Premas Biotech on Thursday said its vaccine candidate for COVID-19 treatment has shown positive results, inducing a neutralising immune response in animal studies. The company is in talks with the Indian regulatory authorities concerned to plan and initiate next steps towards conducting human trials, Premas Biotech said in a statement.

“We are happy to report that the vaccine candidate study in mice has gone on well, and the results are positive and encouraging. We have engaged with the regulatory authorities in India and are working towards the next steps under their guidance,” Premas Biotech Co-Founder and MD Prabuddha Kundu said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Common cold in past may provide protection from COVID-19: Study
2COVID-19 antibody seroprevalence down at 25 pc in Delhi: Survey report in HC
3Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment